ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Jialin Li
Matched on ORCID iD 0000-0002-6069-1822; OpenAlex author ID A5024691043. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer. Co-author DOI 10.1016/j.ccell.2026.08.012↗
- Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2022.101561↗
- Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarc… Co-author DOI 10.1186/s13063-023-07456-0↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Miaoyan Wei · 3 shared papers, 2023–2026 · strength 0.63
- Paper Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancre… DOI 10.1016/j.ccell.2026.08.012↗
- Paper Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal ad… DOI 10.1016/j.tranon.2022.101561↗
- Paper Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resec… DOI 10.1186/s13063-023-07456-0↗
- Xianjun Yu · 3 shared papers, 2023–2026 · strength 0.63
- Paper Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancre… DOI 10.1016/j.ccell.2026.08.012↗
- Paper Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal ad… DOI 10.1016/j.tranon.2022.101561↗
- Paper Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resec… DOI 10.1186/s13063-023-07456-0↗
- Si Shi · 3 shared papers, 2023–2026 · strength 0.63
- Paper Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancre… DOI 10.1016/j.ccell.2026.08.012↗
- Paper Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal ad… DOI 10.1016/j.tranon.2022.101561↗
- Paper Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resec… DOI 10.1186/s13063-023-07456-0↗
- Bo Zhang · 2 shared papers, 2023 · strength 0.34
- Paper Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal ad… DOI 10.1016/j.tranon.2022.101561↗
- Paper Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resec… DOI 10.1186/s13063-023-07456-0↗
- Wei Wang · 2 shared papers, 2023 · strength 0.34
- Paper Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal ad… DOI 10.1016/j.tranon.2022.101561↗
- Paper Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resec… DOI 10.1186/s13063-023-07456-0↗
- Jin Xu · 1 shared paper, 2026 · strength 0.29
- Jin Xu · 1 shared paper, 2023 · strength 0.18
- Xiaomeng Liu · 1 shared paper, 2023 · strength 0.18
- Hang Xu · 1 shared paper, 2023 · strength 0.18
- Qingcai Meng · 1 shared paper, 2023 · strength 0.17
- Jie Hua · 1 shared paper, 2023 · strength 0.17
- Chen Liang · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.